Methenamine (Hiprex): Your brand is changing
Methenamine tablets are changing brand from Hiprex to U-Tract.
People who take methenamine
Sometime after 1 December 2026, your pharmacist will give you the new brand of methenamine, U-Tract.
The same active ingredient, in the same amount
U-Tract is designed to work in your body the same way as Hiprex. It has the same amount of active ingredient. You should not notice any difference, but if you do, please contact your doctor.
The tablets look similar
Both tablets are white and oblong shaped with a score on one side. The old Hiprex tablets have "HX" on one side of the tablet, while the new U-Tract tablets have "H1". Note, the score line is not an aid for breaking the tablet.
Why is this happening?
This is a tender brand change. Every year Pharmac runs a tender process to create competition among suppliers. This helps Pharmac manage the costs of medicines and allows us to supply as many medicines as possible to New Zealanders. Any savings we make go back into the medicines budget to help pay for new medicines.
Pharmacists
Inova brand (Hiprex) 1 g tablets will be delisted (no longer funded) from 1 May 2027. This allows time to dispense and claim any remaining stock of Inova brand (Hiprex) before moving to Miro brand (U-Tract).
- Chemical: Methenamine (hexamine) hippurate
- Brand: Inova
- Pharmacode: 209538 and 2671077
- Subsidy: $19.95
- Measure / Qty: per 100
U-Tract (Miro) 1 g tablets will be listed (funded) from 1 December 2026.
- Chemical: Methenamine (hexamine) hippurate
- Brand: Miro Healthcare Limited
- Pharmacode: 2737051
- Subsidy: $13.80
- Measure / Qty: per 100
While U-Tract will be listed (funded) from 1 December, stock may not be available until mid-December. Please continue to order Hiprex in the interim.
Download a flyer about this brand change
- Methenamine - brand change flyer_A5_Nov 2026 [PDF 194 KB]
Key dates
- 1 December 2026 | U-Tract will be listed (funded).
- 1 May 2027 | U-Tract will have Principal Supply Status (PSS).
- 1 May 2027 | Hiprex tab 1 g will be delisted (no longer funded).
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)